<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39373031</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1364-548X</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>85</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Chemical communications (Cambridge, England)</Title><ISOAbbreviation>Chem Commun (Camb)</ISOAbbreviation></Journal><ArticleTitle>Electrochemically grafted gallic acid-chitosan: a metal-free <i>in situ</i> redox platform for regiospecific oligopeptide-viral spike protein interaction.</ArticleTitle><Pagination><StartPage>12405</StartPage><EndPage>12408</EndPage><MedlinePgn>12405-12408</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1039/d4cc04954c</ELocationID><Abstract><AbstractText>Electrochemical grafting of gallic acid with chitosan (EgGC) voltammetrically deposited on a multitude of substrates exhibiting reversible oxidoreduction suitable for sensor construction is reported. A bioreceptor customized from the fragment antigen binding region of SARS-CoV-2 neutralizing antibodies immobilized on an EgGC matrix supported the selective/specific electrochemical signal transduction with respect to different viral loads (femtogram level) of SARS-CoV-2.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Vinoth</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-1493-7606</Identifier><AffiliationInfo><Affiliation>Electrodics and Electrocatalysis Division, CSIR-Central Electrochemical Research Institute (CECRI), Karaikudi, 630 003, Tamil Nadu, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research (AcSIR), Ghaziabad-201 002, India. vmurugan@cecri.res.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivakumar</LastName><ForeName>Chinnaiah</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Electrodics and Electrocatalysis Division, CSIR-Central Electrochemical Research Institute (CECRI), Karaikudi, 630 003, Tamil Nadu, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research (AcSIR), Ghaziabad-201 002, India. vmurugan@cecri.res.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Kannadasan Anand</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0002-9910-2044</Identifier><AffiliationInfo><Affiliation>Anderson Clinical Genetics, Anderson Diagnostics and Labs, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vigneswari</LastName><ForeName>Sevakumaran</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Climate Adaptation and Marine Biotechnology (ICAMB), Kuala Nerus 21030, Terengganu, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakshminarayanan</LastName><ForeName>Rajamani</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8214-5315</Identifier><AffiliationInfo><Affiliation>Ocular Infections and Antimicrobials Research Group, Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower, Singapore 169856, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Sudhakar</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2096-2648</Identifier><AffiliationInfo><Affiliation>Department of Virology and Biotechnology, ICMR-National Institute for Research in Tuberculosis (NIRT), Chennai 600031, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veerapandian</LastName><ForeName>Murugan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4319-6712</Identifier><AffiliationInfo><Affiliation>Electrodics and Electrocatalysis Division, CSIR-Central Electrochemical Research Institute (CECRI), Karaikudi, 630 003, Tamil Nadu, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Scientific &amp; Innovative Research (AcSIR), Ghaziabad-201 002, India. vmurugan@cecri.res.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Chem Commun (Camb)</MedlineTA><NlmUniqueID>9610838</NlmUniqueID><ISSNLinking>1359-7345</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>632XD903SP</RegistryNumber><NameOfSubstance UI="D005707">Gallic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>9012-76-4</RegistryNumber><NameOfSubstance UI="D048271">Chitosan</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005707" MajorTopicYN="Y">Gallic Acid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048271" MajorTopicYN="Y">Chitosan</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="Y">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055664" MajorTopicYN="Y">Electrochemical Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015374" MajorTopicYN="N">Biosensing Techniques</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39373031</ArticleId><ArticleId IdType="doi">10.1039/d4cc04954c</ArticleId></ArticleIdList></PubmedData></PubmedArticle>